Key facts
- This page summarizes Masoud Toloue's Form 4 filing for Quanterix Corp (QTRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Feb 2025, 17:00.
Masoud Toloue - 04 Feb 2025 Form 4 Insider Report for Quanterix Corp (QTRX)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- QTRX
- Reported as of
- 04 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Feb 2025, 17:00:43 UTC
- Prior SEC filing
- 04 Feb 2025
- Next SEC filing
- 19 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Keane, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Masoud Toloue filed Form 4 for Quanterix Corp (QTRX) on 06 Feb 2025.
Change
- Previous filing in this sequence was filed on 04 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QTRX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +138,790
- Change %
- +41%
- Price
- $0.000000
- Shares after
- 478,509
- Date
- 04 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QTRX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +454,641
- Change %
- Price
- $0.000000
- Shares after
- 454,641
- Date
- 04 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 454,641
- Exercise price
- $8.43
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 4, 2026, and the remaining 75% vest in 36 equal monthly installments on the 15th of each month beginning on March 15, 2026.
Footnote F2
Includes 258,027 restricted stock units.
Footnote F3
The option vests as to 25% of the shares on February 4, 2026, and the remaining 75% vests in 36 equal monthly installments on the 15th of each month beginning on March 15, 2026.